Homepage > Rare diseases > Search

Search for a rare disease

*
(*) mandatory field

Vitamin B12-unresponsive methylmalonic acidemia type mut-

Suggest an update
Your message has been sent Your message has not been sent. Please contact an administrator.
Disease definition

Vitamin B12-unresponsive methylmalonic acidemia type mut- is an inborn error of metabolism characterized by recurrent ketoacidotic comas or transient vomiting, dehydration, hypotonia and intellectual deficit, which does not respond to administration of vitamin B12.

ORPHA:79312

Classification level: Subtype of disorder

Synonym(s):
  • Partial deficiency of methylmalonyl-CoA mutase
  • Vitamin B12-unresponsive methylmalonic aciduria type mut-

Prevalence: Unknown

Inheritance: Autosomal recessive

Age of onset: Infancy, Neonatal

ICD-10: E71.1

ICD-11: 5C50.E0

OMIM: 251000

UMLS: C0342719

Summary
Epidemiology

Prevalence of this form of the disorder is not known. More than 450 cases have been reported to date.

Clinical description

The disease typically presents very early in life (<1 to 4 weeks), although later onset cases have been observed, with features including lethargy, failure to thrive, recurrent vomiting, dehydration, respiratory distress, muscle hypotonia, developmental delay, intellectual deficit, hepatomegaly and coma. Patients may show signs of anemia. They may also have potentially life-threatening ketoacidosis and/or hyperammonemia, renal and neurological complications, metabolic stroke and cardiomyopathy. mut- is generally less severe than vitamin B12-unresponsive methylmalonic acidemia type mut0 and may in some cases respond to vitamin B12 therapy. Long term complications include metabolic stroke and development of end stage renal failure. These complications are more frequent in mut0 than in mut-.

Etiology

The disease is caused by partial deficiency in the activity of the mitochondrial vitamin B12-dependent enzyme methylmalonyl-CoA mutase which is a result of mutations in the MUT gene (6p21).

Genetic counseling

It is transmitted as an autosomal recessive trait.

Last update: February 2012 - Expert reviewer(s): Dr David ROSENBLATT
A summary on this disease is available in Français, Español, Deutsch, Italiano, Nederlands Polski
Detailed information

Logo ERN: produced/endorsed by ERN(s) Logo FSMR: produced/endorsed by FSMR(s)

General public
Guidelines
Emergency guidelines
English (2012.pdf) - Brit Inher Metab Dis Group
Anesthesia guidelines
English (2017) - Orphananesthesia
Čeština (2017) - Orphananesthesia
Clinical practice guidelines
English (2024) - Kidney Int Rep
English (2025) - Kidney Int Rep
English (2021) - J Inherit Metab Dis
English (2014) - Orphanet J Rare Dis
Disease review articles
Clinical genetics review
English (2022) - GeneReviews
The documents contained in this website are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.